Key terms
About CASI
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market. The company was founded in 1991 and is headquartered in Beijing, China.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CASI news
May 03
9:01am ET
Casi Pharmaceuticals files $50M mixed securities shelf
Apr 08
5:03pm ET
Casi Pharmaceuticals discloses development relating to dispute with Juventas
Mar 05
9:45am ET
CASI Pharmaceuticals trading resumes
Mar 05
9:40am ET
CASI Pharmaceuticals trading halted, volatility trading pause
Mar 05
7:07am ET
Casi Pharmaceuticals’ BI-1206 shows positive interim Phase 1 data in iNHL
Feb 16
7:01am ET
Casi Pharmaceuticals announces first dosing of FOLOTYN in China
No recent press releases are available for CASI
CASI Financials
Key terms
Ad Feedback
CASI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CASI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range